Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Gynecologie, Obstetrique & Fertilite|June 10, 2008
[Postmenopausal osteoporosis: when is it necessary to perform laboratory testing? Which testing strategy?]C Frayssinet, F TrémollieresClimacteric : the Journal of the International Menopause Society|January 10, 2019
Assessment and hormonal management of osteoporosisF TrémollieresGynecologie, Obstetrique & Fertilite|January 17, 2012
[Oral combined contraception: is there any difference between ethinyl-estradiol and estradiol?]F TrémollieresGynecologie, Obstetrique & Fertilite|March 30, 2007
[Hormone replacement therapy in postmenopausal women: all the treatments are not the same]C Ribot, F TrémollieresFood Additives and Contaminants|April 1, 1984
The principle of a threshold dose in chemical carcinogenesisC FrayssinetGynecologie, Obstetrique & Fertilite|December 27, 2008
[How to prevent early postmenopausal fracture risk? Proposition of a strategy]F Trémollieres, J-M Pouilles, C RibotGynecologie, Obstetrique, Fertilite & Senologie|March 23, 2021
[Menopause, menopause hormone therapy and osteoporosis. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]J-M Pouillès, A Gosset, F TrémollieresBulletin Du Cancer|January 1, 1990
[Concept of tumor promoters in hepatocarcinogenesis]C Frayssinet, C Lafarge-FrayssinetCancer Letters|March 1, 1989
Over expression of proto-oncogenes: ki-ras, fos and myc in rat liver cells treated in vitro by two liver tumor promoters: phenobarbital and biliverdinC Lafarge-Frayssinet, C FrayssinetPageof 7